20 Microns Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 3:12 am

Competitors of 20 Microns Ltd

All Competitor Stocks of 20 Microns Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:05 am

Below is a detailed analysis of the quarterly data for 20 Microns Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 20.00 Cr..
• For Expenses, as of Jun 2025, the value is 216.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 199.00 Cr. (Mar 2025) to 216.00 Cr., marking an increase of 17.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Mar 2025) to 26.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.78. The value appears strong and on an upward trend. It has increased from 4.31 (Mar 2025) to 4.78, marking an increase of 0.47.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:49 am

Growth

Last Updated: September 4, 2025, 9:45 pm

Balance Sheet

Last Updated: June 16, 2025, 12:35 pm

Below is a detailed analysis of the balance sheet data for 20 Microns Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
• For Reserves, as of Mar 2025, the value is 412.00 Cr.. The value appears strong and on an upward trend. It has increased from 335.00 Cr. (Mar 2024) to 412.00 Cr., marking an increase of 77.00 Cr..
• For Borrowings, as of Mar 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 121.00 Cr. (Mar 2024) to 165.00 Cr., marking an increase of 44.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Mar 2024) to 120.00 Cr., marking an increase of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 715.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 588.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 127.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 284.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2024) to 284.00 Cr., marking an increase of 72.00 Cr..
• For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 396.00 Cr.. The value appears strong and on an upward trend. It has increased from 347.00 Cr. (Mar 2024) to 396.00 Cr., marking an increase of 49.00 Cr..
• For Total Assets, as of Mar 2025, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 588.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 127.00 Cr..

Notably, the Reserves (412.00 Cr.) exceed the Borrowings (165.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for 20 Microns Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
• For Diluted EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
• For Cash EPS (Rs.), as of Mar 25, the value is 22.88. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 22.88, marking an increase of 2.94.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 258.68. It has increased from 220.34 (Mar 24) to 258.68, marking an increase of 38.34.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 34.33. This value is within the healthy range. It has increased from 30.95 (Mar 24) to 34.33, marking an increase of 3.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 29.16. This value is within the healthy range. It has increased from 26.88 (Mar 24) to 29.16, marking an increase of 2.28.
• For PBT / Share (Rs.), as of Mar 25, the value is 23.43. This value is within the healthy range. It has increased from 21.77 (Mar 24) to 23.43, marking an increase of 1.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 17.71. This value is within the healthy range. It has increased from 15.87 (Mar 24) to 17.71, marking an increase of 1.84.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
• For PBDIT Margin (%), as of Mar 25, the value is 13.27. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 13.27, marking a decrease of 0.77.
• For PBIT Margin (%), as of Mar 25, the value is 11.27. This value is within the healthy range. It has decreased from 12.19 (Mar 24) to 11.27, marking a decrease of 0.92.
• For PBT Margin (%), as of Mar 25, the value is 9.05. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 9.05, marking a decrease of 0.83.
• For Net Profit Margin (%), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 7.20 (Mar 24) to 6.84, marking a decrease of 0.36.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.83. This value is below the healthy minimum of 8. It has decreased from 7.21 (Mar 24) to 6.83, marking a decrease of 0.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.52. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 14.52, marking a decrease of 1.36.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.77. This value is within the healthy range. It has decreased from 23.69 (Mar 24) to 20.77, marking a decrease of 2.92.
• For Return On Assets (%), as of Mar 25, the value is 8.72. This value is within the healthy range. It has decreased from 9.50 (Mar 24) to 8.72, marking a decrease of 0.78.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.35, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.40. There is no change compared to the previous period (Mar 24) which recorded 1.40.
• For Current Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.71, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.98, marking a decrease of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.70. This value is within the healthy range. It has increased from 3.65 (Mar 24) to 6.70, marking an increase of 3.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.07. This value is below the healthy minimum of 20. It has increased from 4.72 (Mar 24) to 7.07, marking an increase of 2.35.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 20. It has increased from 3.75 (Mar 24) to 5.47, marking an increase of 1.72.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.93. This value exceeds the healthy maximum of 70. It has decreased from 95.28 (Mar 24) to 92.93, marking a decrease of 2.35.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.53. This value exceeds the healthy maximum of 70. It has decreased from 96.25 (Mar 24) to 94.53, marking a decrease of 1.72.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 6.63 (Mar 24) to 6.67, marking an increase of 0.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.55. This value is within the healthy range. It has increased from 4.50 (Mar 24) to 4.55, marking an increase of 0.05.
• For Enterprise Value (Cr.), as of Mar 25, the value is 791.16. It has increased from 563.53 (Mar 24) to 791.16, marking an increase of 227.63.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.86, marking an increase of 0.14.
• For EV / EBITDA (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 6.53, marking an increase of 1.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 92.92. This value exceeds the healthy maximum of 70. It has decreased from 95.27 (Mar 24) to 92.92, marking a decrease of 2.35.
• For Price / BV (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.57, marking an increase of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.09, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness